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Abstract 
During the last decade the incidence of both metabolic syndrome (MS) and depression have been increased in elderly. 
The aim of this study was to examine the association between MS and the depression in a group of old people. We 
ascertained that MS is directly associated with depression in elderly and gender do influence the onset of depression, 
women being more affected than men, independently of the presence of the MS. In these circumstances, the 
prophylactic approach of the MS may reduce the incidence of depression in elderly. 
© 2011 Published by Elsevier Ltd. Selection and peer-review under responsibility of PSIWORLD 2011 
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1. Introduction 
Metabolic syndrome (MS) represents today a public health problem due to severe multisystem 
consequences it induces, affecting large groups of people, especially of third age. MS includes a 
constellation of conditions that determine a high risk for coronary artery disease: type 2 diabetes 
(impaired fasting glucose or insulin resistance), obesity, hypertension, dyslipidemia with elevated low 
density lipoprotein (LDL) cholesterol, low high density lipoprotein (HDL) and elevated triglycerides 
(Rigo et al., 2009). 
Depression is another geriatric health problem, with many complications on long term, generating an 
important number of handicapped people. World Health Organization (WHO) considers depression as the 
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leading causes of disability worldwide, women being twice as likely to suffer depression as men (Patel, 
2001).
During the last decade the incidence of both MS and depression have been increased in elderly. The 
association between MS and depression remain unclear, especially in elderly, due to comorbidity which 
increases with age. Some recent researches indicated that MS is highly prevalent among elderly with 
current major depression (Heiskanen et al., 2006). Certainly, the prevalence of MS and depression in the 
elderly seems to be associated with the age category (Wild et al., 2011, Ravaglia et al., 2006). 
In present a research necessity in geriatric mental health is represented by the investigation of the 
association between affective diseases and other health priorities. In this context, the aim of this study 
was to examine the association between MS and the depression in a group of old people and to explain 
the relation between these variables.   
2. Material and methods  
We applied on a group of 42 old people with MS (average age 68.6 years, sex ratio 1/1) the Yesevage 
Geriatric Depression Scale (GDS) and we compare the scores with the ones the scores with the ones of a 
witness group of elderly, without any form of MS (N=42, average age 69.2 years, sex ratio 1/1). The GDS 
(short version) is a generally valid measure of depressive symptoms in elderly that is used in the 
Romanian geriatrics and gerontology units. 
For the MS diagnostic we used the revised criteria of the National Cholesterol Education Program 
Adult Treatment Panel III – NCEP ATP III (Bener et al., 2009). 
We applied the t test in order to determine the statistical significance of differences between means 
(GDS scores) among the two groups and the Pearson’s chi-squared test as a tool to investigate whether 
distributions of depression differ in the study groups. 
3. Findings 
Regarding the manifestations of MS in the subjects of the first group, high cholesterol and triglyceride 
levels and central obesity were significantly higher, 64.3% of them reporting antecedents of 
cardiovascular diseases. 
We calculated the differences between our groups regarding the presence of depressive symptoms: the 
first group scored higher than the second one (t = 3.13 and p d 0.002) and we can conclude that MS is 
directly associated with depression in elderly (fig. 1). 
Fig. 1. The differences between means (GDS scores) between the two groups. 
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As we can see in figure 2, the prevalence of depression (diagnosed using a higher score than 5 points at 
the GDS) in the first group, with MS, was 40.4% compared with 16.6% in the second group, without MS 
(chi-squared = 5.83 and p d 0.02).  
Fig. 2. The prevalence of depression in the two groups. 
In addition, it seems that gender does influence the onset of depression, independently of the presence 
of the MS, women being twice more affected than men for the entire group of subjects (chi-squared = 
3.73 and p d 0.05). Thus, the prevalence of depression among men was 19% and 38% among women, 
respectively (fig. 3) 
Fig. 3. The prevalence of depression in the entire group according to gender. 
The MS seems to be associated with depression especially in men (on the entire group of subjects 75% 
of men with MS had depression and only 68.75% of women with MS had depression), but the results can 
be extrapolated with some reluctance due to the relative small number of subjects in subgroups when we 
take into consideration the gender factor. 
In any case, the increasing prevalence of MS in elderly could at least partially be explained by the 
increasing prevalence of depression. Recent findings allow establishing links between the pattern of 
metabolic diseases, cardiovascular diseases and depression, according to the neuroendocrine theory of 
aging. This theory identifies a cluster of conditions (hypertension, obesity, dyslipidemia, diabetes type 2, 
menopause, late onset depression, vascular cognitive impairment, impairment of immune defense and 
some forms of cancer) as age-associated neuroendocrine disorders (Oxenkrug, 2010). 
From this perspective, our results are in concordance with other studies: beyond the association 
between these two morbidities, both depression and metabolic syndrome remain significant predictors of 
cardio-vascular diseases (Vaccarino et al., 2008). 
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4. Conclusion 
We reported a direct association between MS and depression, the absence of MS representing a 
protection from the onset of depression at third age patients, especially for men. In the same time, the 
presence  of  MS  raises  the  risk  of  depression  onset  in  elderly  population,  for  both  genders.  In  these  
circumstances, the prophylactic approach of the MS, considering the characteristics induced by gender, 
may reduce the incidence of depression in elderly.  
Moreover, it is recommended that elderly with MS be screened for affective disorders in order to 
detect the depression patients in an early stage that could be cured more efficiently. 
Future researches on larger groups are necessary to facilitate the identification of which criteria of the 
metabolic syndrome (obesity, hypertension, insulin resistance, glucose intolerance and dyslipidemia) are 
mostly correlated with the presence of depression in elderly. 
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